home / stock / lixt / lixt news

LIXT News and Press, Lixte Biotechnology Holdings Inc. From 04/18/22

Stock Information
Company Name: Lixte Biotechnology Holdings Inc.
Stock Symbol: LIXT
Market: OTC
Website: lixte.com
Menu
LIXT LIXT Quote LIXT Short LIXT News LIXT Articles LIXT Message Board
Get LIXT Alerts

News, Short Squeeze, Breakout and More Instantly...
LIXT - Natus Medical, MedAvail top healthcare gainers; Nektar, TG Therapeutics lead losers' pack

Gainers: Natus Medical (NTUS) +30%. MedAvail (MDVL) +25%. IMARA (IMRA) +13%. Frequency Therapeutics (FREQ) +11%. Lyra Therapeutics (LYRA) +4%. Losers: Nektar Therapeutics (NKTR) -36%. TG Therapeutics (TGTX) -24%. Lixte Biotechnology (LIXT) -15%.&#x...
LIXT - Penny Stocks to Buy For Your Watchlist Next Week 

3 Penny Stocks to Add to Your Watchlist This Coming Week There’s a lot of debate surrounding penny stocks – are they worth investing in? Some people believe that penny stocks are a huge gamble, while others view them as a great way to make money. So, what’s the trut...

LIXT - LIXTE Biotechnology Announces the Closing of $5.8 Million Registered Direct Offering Priced At-The-Market

PASADENA, CA, April 14, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, today announced that it has closed a registered direct offering with certai...

LIXT - WallachBeth Capital Announces Completion of LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) $5.8 Million Registered Direct Offering

WallachBeth Capital Announces Completion of LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) $5.8 Million Registered Direct Offering PR Newswire JERSEY CITY, N.J. , April 14, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and...
LIXT - VSTM, ZY and SGLY among mid-day movers

Gainers: MedAvail Holdings (MDVL) +51%. Borqs Technologies (BRQS) +27%. Verastem (VSTM) +26%. Lexaria Bioscience (LEXX) +22%. Splash Beverage Group (SBEV) +18%. HighPeak Energy (HPK) +17%. Cardiol Therapeutics (CRDL) +16%. Airgain (AIRG) +15%. CoreCivic (CXW) +14%. Renren (RENN) +13%. Losers:...

LIXT - Lexaria, Rite Aid top healthcare gainers; Protagonist, Lixte Biotechnology lead losers' pack

Gainers: Lexaria Bioscience (LEXX) +23%. Rite Aid (RAD) +14%. Inozyme Pharma (INZY) +12%. Finch Therapeutics (FNCH) +11%. Valneva (VALN) +9%. Losers: Protagonist Therapeutics (PTGX) -23%. Lixte Biotechnology (LIXT) -10%. Biofrontera (BFRI) ...

LIXT - Healthcare Breakthroughs: Atai, Nova Mentis, PolarityTE, and LIXTE; Biomed Leaders Report Latest Advances in Regenerative Tissue Technology, Psychedelics, and New Therapeutics for Autism, Mental Health and Cancers

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: PolarityTE, Inc. (NASDAQ: PTE), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), atai Life Sciences N....
LIXT - WestPark Capital Announces Completion of $5.8 Million Registered Direct Offering Priced At-The-Market for Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT)

WestPark Capital, Inc., a full-services investment bank and securities broker-dealer, today announced the completion of a Registered Direct Offering for Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs f...

LIXT - WallachBeth Capital Announces Purchase and Sale of LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT)

WallachBeth Capital Announces Purchase and Sale of LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) PR Newswire $5.8 Million Registered Direct Offering Priced At-The-Market JERSEY CITY, N.J. , April 13 , 2022 /PRNewswire/ -- WallachBeth ...

LIXT - LIXT Stock Gets 200%+ Lift, Don't Get Caught on the Way Down

InvestorPlace - Stock Market News, Stock Advice & Trading Tips After almost 12 months of underperformance, Lixte Biotechnology (NASDAQ: LIXT ) has skyrocketed by 200% in today’s trade. As an overview, Lixte is a clinical-stage biotechnology company. The massive rally in LI...
Previous 10 Next 10